BlueWind Medical™ Ltd. to Participate in Piper Sandler’s Virtual Healthcare Conference

BlueWind Medical™, the developer of the innovative RENOVA™ iStim implantable neuromodulation device for the treatment of urinary urgency incontinence, has announced its participation in the 33rd Annual Virtual Healthcare Conference organized by Piper Sandler. The conference will take place from November 29th to December 2nd, 2021.

As part of the conference, Daniel Lemaitre, Chairman, and CEO of BlueWind Medical, will be interviewed in a pre-recorded conversation, which will be available through the conference’s website. BlueWind Medical’s management will also be conducting individual meetings with investors on November 29th.

“We appreciate the opportunity Piper Sandler has given BlueWind Medical to share some insight into our product and our plans moving forward,” said Lemaitre.

Overactive bladder affects over 33 million Americans, according to the American Urological Association. BlueWind Medical was founded in Israel in 2010 to capitalize on unique neuromodulation technology that has the potential to treat multiple medical conditions. CE Mark for use in the treatment of overactive bladder was obtained in 2016.

Piper Sandler hosts several client conferences and events each year focusing on agriculture, clean technology & renewables, consumer, energy, financial services, healthcare, industrials, and technology. The goal of each conference is to bring together key industry executives, investors, and professionals to provide multiple perspectives, investigate critical trends, and identify the leaders in the markets that are driving our economy.

For additional information, please visit BluewindMedical.com. For press inquiries, please contact Daniel Dean at daniel@rothivy.com or call 818-665-6188.